DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 3, 1996, Pages 245-253

  Delmastro, Dean A ^a   Li, Jibin ^a   Vaisman, Alexandra ^a   Solle, Michael ^a   Chaney, Staphen G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; Drug resistance; Gene expression

Indexed keywords

ALPHA ACTIN; CISPLATIN; MESSENGER RNA; PROTEIN P21; TETRAPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL LINE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA SYNTHESIS; DOSE RESPONSE; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C JUN; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RNA HYBRIDIZATION;

EID: 0031060238     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050568     Document Type: Article

References (38)

1. Andrews PA, Albright KD (1992) Mitochondrial detects in cisdiamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res 52: 1895
2. Andrews PA, Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35
3. Andrews PA, Velury S, Mann, SC, Howell, SB (1988) cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48: 68
4. Andrews PA, Jones JA, Varki NM, Howell SB (1990) Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vitro model of human ovarian carcinoma. Cancer Commun 2: 93
5. 2+ increases transcriptional activity and messenger RNA stability. J Biol Chem 267: 20465
6. Choi AMK, Tucker RW, Carlson SG, Wiegand G, Holbrook NJ (1994) Calcium mediates expression of stress-response genes in prostaglandin A(2)-induced growth arrest. FASEB J 8: 1048
7. Devary Y, Gottlieb RA, Lau LF, Karin M (1991) Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11: 2804
8. Dileonardo A, Linke SP, Clarkin K, Wahl GM (1994) DNA damage triggers a prolonged p53-dependent G(1) arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8: 2540
9. Eastman A, Schulte N (1988) Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry 27: 4730
10. El-Deiry WS, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrel M, Hill DE, Wang Y, Winman, KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169
11. Fan SJ, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW, O'Connor PM (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824
12. Fornace AJ Jr, Alamo I Jr, Hollander, MC (1988) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800
13. Fornace, AJ Jr, Nebert, DW, Hollander, MC, Luethy, JD, Papathanasiou, M, Fargnoli, J, Holbrook, NJ (1989) Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9: 4196-4203
14. Gately DP, Jones JA, Christen R, Barton RM, Los G, Howell SB (1994) Induction of the growth arrest and DNA damage inducible gene gadd153 by cisplatin in vitro and in vivo. Br J Cancer 70: 1102
15. Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG (1990) Role of carrier ligand in platinum resistance in L1210 cells. Cancer Res 50: 6497
16. Gibbons GR, Kaufmann WK, Chaney SG (1991) Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Carcinogenesis 12: 2253
17. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr (1993) Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem 268: 24385
18. Hospers GAP, Mulder NH, Jong B de, Ley L de, Uges, DRA, Fichtinger-Schepman AMJ, Scheper RJ, Vries EGE de (1988) Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Cancer Res 48: 6803
19. Jackman J, Alamo I Jr, Fornace AJ Jr (1994) Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res 54: 5656
20. Loehourer PJ, Einhorn LH (1984) Diagnosis and treatment: drugs five years later. Ann Intern Med 100: 704
21. Los G, Barton R, Veelen L van, Woods A, Vicario D, Robbins KT, Howell SB (1994) Association between DNA damage-inducible gene expression and tumor response (abstract). Proc Am Assoc Cancer Res 35: 550
22. Luethy JD, Holbrook NJ (1992) Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 52: 5
23. Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG (1994) Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 54: 3500
24. Mann SC, Andrews PA, Howell SB (1990) Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Chemother Pharmacol 25: 236
25. Ron D, Habener JF (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Genes Dev 6: 439
26. Rubin E, Kharbanda S, Gunji H, Kufe D (1991) Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol Pharmacol 39: 697
27. Rubin E, Kharbanda S, Gunji H, Weichselbaum R, Kufe D (1992) cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway. Cancer Res 52: 878
28. Schmidt W, Chaney SG (1993) Role of carrier ligand in platinum resistance of human carcinoma cell lines. Cancer Res 53: 799
29. Sheikh MS, Li X S, Chen JC, Shao ZM, Ordonez JV, Fontana JA (1994) Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407
30. Sherman SE, Lippard SJ (1987) Structural aspects of platinum anticancer drug interaction with DNA. Chem Rev 87: 1153
31. Smith ML, Chen IT, Zhan QM, Bae IS, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376
32. Sorenson CM, Eastman A (1988) Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. Cancer Res 48: 4484
33. Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574
34. Wyrick SD, Chaney SG (1987) Tritiated platinum antitumor agents containing the trans-(d,l)-1,2-diaminocyclohexane carrier ligand. J Label Compound Radiopharm 25: 349
35. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701
36. Zhan Q, Bae I, Kastan MB, Fornace AJ Jr (1994) The p53-dependent gamma-ray response of gadd45. Cancer Res 54: 2755
37. Zhan Q, Lord KA, Alamo I, Hollander C, Carrier F, Ron D, Kohn KW, Hoffman B, Lieberman DA, Fornace AJ Jr (1994) The gadd and MyoD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14: 2361
38. Zhen WP, Link CJ, O'Connor PM, Reed E, Parker R, Howell SB, Bohour VA (1992) Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol 12: 3689